Kognitive Beeinträchtigungen bei Multipler Sklerose

Lernziele

• Häufigkeit, Art und Bedeutung kognitiver Beeinträchtigungen bei MS einordnen können

• Zusammenhänge mit Erkrankungsdauer, körperlichen Symptomen, Verlaufstyp und psychologischen Aspekten erfahren

• nähere Informationen zu den häufig beeinträchtigten kognitiven Funktionen erwerben

• Überblick über den aktuellen Stand der neuropsychologischen Diagnostik bei MS gewinnen; wissen, zu welchem Zweck welche Verfahren eingesetzt werden können und auf welche Probleme geachtet werden sollte

• erfahren, wie sich kognitive Defizite in MRT-Befunden widerspiegeln können

• Informationen zu Behandlungsmöglichkeiten erhalten

• Literatur

• 1 Charcot J. Lectures on the diseases of the nervous system. London: The New Sydenham Society; 1877
• 2 Messinis L, Kosmidis MH, Lyros E et al. Assessment and rehabilitation of cognitive impairment in multiple sclerosis. Int Rev Psychiatry 2010; 22: 22-34
• 3 Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151
• 4 Amato MP, Zipoli V, Portaccio E. Cognitive changes in multiple sclerosis. Expert Rev Neurother 2008; 8: 1585-1596
• 5 Patti F, Amato MP, Trojano M et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009; 15: 779-788
• 6 Nocentini U, Pasqualetti P, Bonavita S et al. Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler 2006; 12: 77-87
• 7 Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003; 16: 283-288
• 8 Engel C, Greim B, Zettl UK. Diagnostics of cognitive dysfunctions in multiple sclerosis. J Neurol 2007; 254 (Suppl. 02) II/30-II/34
• 9 Amato MP, Portaccio E, Goretti B et al. Cognitive impairment in early stages of multiple sclerosis. Neurol Sci 2010; 31 (Suppl. 02) S211-S214
• 10 Achiron A, Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 2003; 74: 443-446
• 11 Deloire MSA, Salort E, Bonnet M et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 519-526
• 12 Schulz D, Kopp B, Kunkel A et al. Cognition in the early stage of multiple sclerosis. J Neurol 2006; 253: 1002-1010
• 13 Prakash RS, Snook EM, Lewis JM et al. Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis. Mult Scler 2008; 14: 1250-1261
• 14 Feuillet L, Reuter F, Audoin B et al. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2007; 13: 124-127
• 15 Glanz BI, Holland CM, Gauthier SA et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007; 13: 1004-1010
• 16 Potagas C, Giogkaraki E, Koutsis G et al. Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 2008; 267: 100-106
• 17 Khalil M, Enzinger C, Langkammer C et al. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler 2011; 17: 173-180
• 18 Tinnefeld M, Treitz FH, Haase CG et al. Attention and memory dysfunctions in mild multiple sclerosis. Eur Arch Psychiatry Clin Neurosci 2005; 255: 319-326
• 19 Zipoli V, Goretti B, Hakiki B et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler 2010; 16: 62-67
• 20 Olazarán J, Cruz I, Benito-León J et al. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study. Eur Neurol 2009; 61: 87-93
• 21 Jonsson A, Andresen J, Storr L et al. Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study. J Neurol Sci 2006; 245: 77-85
• 22 Amato MP, Ponziani G, Siracusa G et al. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001; 58: 1602-1606
• 23 Achiron A, Barak Y. Cognitive changes in early ms: a call for a common framework. J Neurol Sci 2006; 245: 47-51
• 24 Smestad C, Sandvik L, Landrø NI et al. Cognitive impairment after three decades of multiple sclerosis. Eur J Neurol 2010; 17: 499-505
• 25 Lynch SG, Parmenter BA, Denney DR. The association between cognitive impairment and physical disability in multiple sclerosis. Mult Scler 2005; 11: 469-476
• 26 Brissart H, Morele E, Baumann C et al. Verbal episodic memory in 426 multiple sclerosis patients: impairment in encoding, retrieval or both?. Neurol Sci 2012; 33: 1117-1123
• 27 Thornton AE, Raz N. Memory impairment in multiple sclerosis: a quantitative review. Neuropsychology 1997; 11: 357-366
• 28 Piras MR, Magnano I, Canu EDG et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 2003; 74: 878-885
• 29 Schwid SR, Goodman AD, Weinstein A et al. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial. J Neurol Sci 2007; 255: 57-63
• 30 Bergendal G, Fredrikson S, Almkvist O. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. Eur Neurol 2007; 57: 193-202
• 31 Kujala P, Portin R, Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain 1997; 120: 289-297
• 32 Camp SJ, Stevenson VL, Thompson AJ et al. A longitudinal study of cognition in primary progressive multiple sclerosis. Brain 2005; 128: 2891-2898
• 33 Glanz BI, Healy BC, Hviid LE et al. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. J Neurol Neurosurg Psychiatry 2011; 83: 38-42
• 34 Rogers JM, Panegyres PK. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations. J Clin Neurosci 2007; 14: 919-927
• 35 Langdon DW. Cognition in multiple sclerosis. Curr Opin Neurol 2011; 24: 244-249
• 36 Beatty WW, Goodkin DE, Hertsgaard D et al. Clinical and demographic predictors of cognitive performance in multiple sclerosis: do diagnostic type, disease duration, and disability matter?. Arch Neurol 1990; 47: 305-308
• 37 Patti F. Cognitive impairment in multiple sclerosis. Mult Scler 2009; 15: 2-8
• 38 Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci 2006; 245: 169-175
• 39 Benedict RHB, Bruce JM, Dwyer MG et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006; 63: 1301-1306
• 40 Denney DR, Lynch SG, Parmenter BA. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters. J Neurol Sci 2008; 267: 129-136
• 41 Glad SB, Nyland H, Aarseth JH et al. How long can you keep working with benign multiple sclerosis?. J Neurol Neurosurg Psychiatry 2011; 82: 78-82
• 42 Portaccio E, Stromillo ML, Goretti B et al. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 2009; 73: 498-503
• 43 Zakzanis KK. Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch Clin Neuropsychol 2000; 15: 115-136
• 44 Goldhammer F, Moosbrugger H. Aufmerksamkeit. In: Schweizer K, Hrsg. Leistung und Leistungsdiagnostik. Heidelberg: Springer; 2006: 16-33
• 45 Denney DR, Hughes AJ, Owens EM et al. Deficits in planning time but not performance in patients with multiple sclerosis. Arch Clin Neuropsychol 2012; 27: 148-158
• 46 Denney DR, Lynch SG, Parmenter BA et al. Cognitive impairment in relapsing and primary progressive multiple sclerosis: mostly a matter of speed. J Int Neuropsychol Soc 2004; 10: 948-956
• 47 Tinnefeld M, Wilhelm H, Daum I et al. Kognitive Defizite in frühen Stadien der schubförmigen multiplen Sklerose. Akt Neurol 2008; 35: 2-7
• 48 Callanan MM, Logsdail SJ, Ron MA et al. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. Brain 1989; 112: 361-374
• 49 McCarthy M, Beaumont JG, Thompson R et al. Modality-specific aspects of sustained and divided attentional performance in multiple sclerosis. Arch Clin Neuropsychol 2005; 20: 705-718
• 50 De Sonneville LMJ, Boringa JB, Reuling IEW et al. Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia 2002; 40: 1751-1765
• 51 Denney DR, Gallagher KS, Lynch SG. Deficits in processing speed in patients with multiple sclerosis: evidence from explicit and covert measures. Arch Clin Neuropsychol 2011; 26: 110-119
• 52 Demaree HA, DeLuca J, Gaudino EA et al. Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation. J Neurol Neurosurg Psychiatry 1999; 67: 661-663
• 53 DeLuca J, Chelune GJ, Tulsky DS et al. Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?. J Clin Exp Neuropsychol 2004; 26: 550-562
• 54 Denney DR, Lynch SG. The impact of multiple sclerosis on patients’ performance on the Stroop Test: processing speed versus interference. J Int Neuropsychol Soc 2009; 15: 451-458
• 55 Hoffmann S, Tittgemeyer M, Von Cramon DY. Cognitive impairment in multiple sclerosis. Curr Opin Neurol 2007; 20: 275-280
• 56 Olivares T, Nieto A, Sánchez MP et al. Pattern of neuropsychological impairment in the early phase of relapsing-remitting multiple sclerosis. Mult Scler 2005; 11: 191-197
• 57 Macniven JAB, Davis C, HO MY et al. Stroop performance in multiple sclerosis: information processing, selective attention, or executive functioning?. J Int Neuropsychol Soc 2008; 14: 805-814
• 58 Lengenfelder J, Bryant D, Diamond BJ et al. Processing speed interacts with working memory efficiency in multiple sclerosis. Arch Clin Neuropsychol 2006; 21: 229-238
• 59 Litvan I, Grafman J, Vendrell P et al. Multiple memory deficits in patients with multiple sclerosis: exploring the working memory system. Arch Neurol 1988; 45: 607-610
• 60 Parmenter BA, Shucard JL, Shucard DW et al. Information processing deficits in multiple sclerosis: a matter of complexity. J Int Neuropsychol Soc 2007; 13: 417-423
• 61 Arnett PA. Speed of presentation influences story recall in college students and persons with multiple sclerosis. Arch Clin Neuropsychol 2004; 19: 507-523
• 62 Leavitt VM, Lengenfelder J, Moore NB et al. The relative contributions of processing speed and cognitive load to working memory accuracy in multiple sclerosis. J Clin Exp Neuropsychol 2011; 33: 580-586
• 63 Winkelmann A, Engel C, Apel A et al. Cognitive impairment in multiple sclerosis. J Neurol 2007; 254 (Suppl. 02) II/35-II/42
• 64 Paul RH, Blanco CR, Hames KA et al. Autobiographical memory in multiple sclerosis. J Int Neuropsychol Soc 1997; 3: 246-251
• 65 Kenealy PM, Beaumont GJ, Lintern T et al. Autobiographical memory, depression and quality of life in multiple sclerosis. J Clin Exp Neuropsychol 2000; 22: 125-131
• 66 Demaree HA, Gaudino EA, DeLuca J et al. Learning impairment is associated with recall ability in multiple sclerosis. J Clin Exp Neuropsychol 2000; 22: 865-873
• 67 Rao SM, Leo GJ, Aubin-Faubert PS. On the nature of memory disturbance in multiple sclerosis. J Clin Exp Neuropsychol 1989; 11: 699-712
• 68 DeLuca J, Barbieri-Berger S, Johnson SK. The nature of memory impairments in multiple sclerosis: acquisition versus retrieval. J Clin Exp Neuropsychol 1994; 16: 183-189
• 69 Thornton AE, Raz N, Tucker KA. Memory in multiple sclerosis: contextual encoding deficits. J Int Neuropsychol Soc 2002; 8: 395-409
• 70 Müller SV, George S, Hildebrandt H et al. Leitlinie zur Diagnostik und Therapie von exekutiven Dysfunktionen. Z Neuropsychol 2010; 21: 167-176
• 71 Seiferth NY, Thienel R, Kircher T. Exekutive Funktionen. In: Schneider S, Fink R, Hrsg. Funktionelle MRT in Psychiatrie und Neurologie. Heidelberg: Springer; 2007: 265-277
• 72 Drew M, Tippett LJ, Starkey NJ et al. Executive dysfunction and cognitive impairment in a large community-based sample with multiple sclerosis from New Zealand: a descriptive study. Arch Clin Neuropsychol 2008; 23: 1-19
• 73 Hildebrandt H, Brokate B, Lanz M et al. Exekutivfunktionsleistungen bei Patienten mit multipler Sklerose. Akt Neurol 2003; 30: 118-126
• 74 Roca M, Torralva T, Meli F et al. Cognitive deficits in multiple sclerosis correlate with changes in fronto-subcortical tracts. Mult Scler 2008; 14: 364-369
• 75 Drew MA, Starkey NJ, Isler RB. Examining the link between information processing speed and executive functioning in multiple sclerosis. Arch Clin Neuropsychol 2009; 24: 47-58
• 76 Henry JD, Beatty WW. Verbal fluency deficits in multiple sclerosis. Neuropsychologia 2006; 44: 1166-1174
• 77 Connick P, Kolappan M, Bak TH et al. Verbal fluency as a rapid screening test for cognitive impairment in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2012; 83: 346-347
• 78 Kleeberg J, Bruggimann L, Annoni JM et al. Altered decision-making in multiple sclerosis: a sign of impaired emotional reactivity?. Ann Neurol 2004; 56: 787-795
• 79 Nagy H, Bencsik K, Rajda CÍL et al. The effects of reward and punishment contingencies on decision-making in multiple sclerosis. J Int Neuropsychol Soc 2006; 12: 559-565
• 80 Simioni S, Ruffieux C, Kleeberg J et al. Preserved decision making ability in early multiple sclerosis. J Neurol 2008; 255: 1762-1769
• 81 Simioni S, Ruffieux C, Kleeberg J et al. Progressive decline of decision-making performances during multiple sclerosis. J Int Neuropsychol Soc 2009; 15: 291-295
• 82 Vleugels L, Lafosse C, van Nunen A et al. Visuoperceptual impairment in multiple sclerosis patients diagnosed with neuropsychological tasks. Mult Scler 2000; 6: 241-254
• 83 Rao SM, Leo GJ, Bernardin L et al. Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-691
• 84 Grossman M, Robinson KM, Onishi K et al. Sentence comprehension in multiple sclerosis. Acta Neurol Scand 1995; 92: 324-331
• 85 Ghaffar O, Feinstein A. APOE epsilon4 and cognitive dysfunction in multiple sclerosis: a review. J Neuropsychiatry Clin Neurosci 2010; 22: 155-165
• 86 Carmona O, Masuet C, Santiago O et al. Multiple sclerosis and cognitive decline: is ApoE-4a surrogate marker?. Acta Neurol Scand 2011; 124: 258-263
• 87 Perneczky R, Alexopoulos P, Schmid G et al. Kognitive Reservekapazität und ihre Bedeutung für Auftreten und Verlauf der Demenz. Nervenarzt 2011; 82: 325-335
• 88 Sumowski JF, Chiaravalloti N, DeLuca J. Cognitive reserve protects against cognitive dysfunction in multiple sclerosis. J Clin Exp Neuropsychol 2009; 31: 913-926
• 89 Sumowski JF, Wylie GR, Chiaravalloti N et al. Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis. Neurology 2010; 74: 1942-1945
• 90 Sumowski JF, Wylie GR, Gonnella A et al. Premorbid cognitive leisure independently contributes to cognitive reserve in multiple sclerosis. Neurology 2010; 75: 1428-1431
• 91 Benedict R, Morrow S, Weinstock Guttman B et al. Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. J Int Neuropsychol Soc 2010; 16: 829-835
• 92 Sumowski JF, Wylie GR, DeLuca J et al. Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve. Brain 2010; 133: 362-374
• 93 Arnett PA. Does cognitive reserve apply to multiple sclerosis?. Neurology 2010; 74: 1934-1935
• 94 Pierson SH, Griffith N. Treatment of cognitive impairment in multiple sclerosis. Behav Neurol 2006; 17: 53-67
• 95 Benedict RHB, Fischer JS, Archibald CJ et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002; 16: 381-397
• 96 Ferreira MLB. Cognitive deficits in multiple sclerosis: a systematic review. Arq Neuropsiquiatr 2010; 68: 632-641
• 97 Foong J, Rozewicz L, Quaghebeur G et al. Neuropsychological deficits in multiple sclerosis after acute relapse. J Neurol Neurosurg Psychiatry 1998; 64: 529-532
• 98 Morrow SA, Jurgensen S, Forrestal F et al. Effects of acute relapses on neuropsychological status in multiple sclerosis patients. J Neurol 2011; 258: 1603-1608
• 99 Scherer P. Cognitive screening in multiple sclerosis. J Neurol 2007; 254 (Suppl. 02) II/26-II/29
• 100 Beatty WW, Goodkin DE. Screening for cognitive impairment in multiple sclerosis: an evaluation of the Mini-Mental State Examination. Arch Neurol 1990; 47: 297-301
• 101 Scherer P, Baum K, Bauer H et al. Normierung der Brief Repeatable Battery of Neuropsychological Tests (BRB-N) für den deutschsprachigen Raum. Nervenarzt 2004; 75: 984-990
• 102 Tombaugh TN. A comprehensive review of the paced auditory serial addition test (PASAT). Arch Clin Neuropsychol 2006; 21: 53-76
• 103 Rosti E, Hämäläinen P, Koivisto K et al. PASAT in detecting cognitive impairment in relapsing-remitting MS. Appl Neuropsychol 2007; 14: 101-112
• 104 Younes M, Hill J, Quinless J et al. Internet-based cognitive testing in multiple sclerosis. Mult Scler 2007; 13: 1011-1019
• 105 Deloire MSA, Bonnet MC, Salort E et al. How to detect cognitive dysfunction at early stages of multiple sclerosis?. Mult Scler 2006; 12: 445-452
• 106 Aupperle RL, Beatty WW, Shelton FdeNap. Three screening batteries to detect cognitive impairment in multiple sclerosis. Mult Scler 2002; 8: 382-389
• 107 Brooks JBB, Giraud VO, Saleh YJ et al. Paced auditory serial addition test (PASAT): a very difficult test even for individuals with high intellectual capability. Arq Neuropsiquiatr 2011; 69: 482-484
• 108 Drake AS, Weinstock-Guttman B, Morrow SA et al. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler 2010; 16: 228-237
• 109 Forn C, Belenguer A, Belloch V et al. Anatomical and functional differences between the Paced Auditory Serial Addition Test and the Symbol Digit Modalities Test. J Clin Exp Neuropsychol 2011; 33: 42-50
• 110 Gow AJ, Deary IJ. Is the PASAT past it? Testing attention and concentration without numbers. J Clin Exp Neuropsychol 2004; 26: 723-736
• 111 Rao SM. A manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis. New York: National Multiple Sclerosis Society; 1990
• 112 Amato MP, Portaccio E, Goretti B et al. The Rao’s Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler 2006; 12: 787-793
• 113 Buschke H. Selective reminding for analysis of memory and learning. Journal of Verbal Learning and Verbal Behavior 1973; 12: 543-550
• 114 Göhler H. Zwei neuropsychologische Testbatterien als Screeningtests bei sekundär progredienter Multipler Sklerose – Vergleich mit einem Normkollektiv. Freie Universität Berlin, Universitätsbibliothek; 2005
• 115 Schultheis MT, Weisser V, Ang J et al. Examining the relationship between cognition and driving performance in multiple sclerosis. Arch Phys Med Rehabil 2010; 91: 465-473
• 116 Boringa JB, Lazeron RHC, Reuling IEW et al. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 2001; 7: 263-267
• 117 Strober L, Englert J, Munschauer F et al. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler 2009; 15: 1077-1084
• 118 Portaccio E, Goretti B, Zipoli G et al. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. Clin Neuropsychol 2009; 23: 268-275
• 119 Benedict RHB, Cookfair D, Gavett R et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12: 549-558
• 120 Benedict RHB, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. J Neurol 2007; 254 (Suppl. 02) II/22-II/25
• 121 Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung: TAP (Version 2.2). Herzogenrath: Psytest; 2009
• 122 Powlishta KK, Von Dras DD, Stanford A et al. The clock drawing test is a poor screen for very mild dementia. Neurology 2002; 59: 898-903
• 123 Ehreke L, Luppa M, König HH et al. Is the Clock Drawing Test a screening tool for the diagnosis of mild cognitive impairment? A systematic review. Int Psychogeriatr 2010; 22: 56-63
• 124 Barak Y, Lavie M, Achiron A. Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test. J Clin Neurosci 2002; 9: 629-632
• 125 Scherer P, Penner IK, Rohr A et al. The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study. Mult Scler 2007; 13: 402-411
• 126 Parmenter BA, Zivadinov R, Kerenyi L et al. Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis. J Clin Exp Neuropsychol 2007; 29: 215-223
• 127 Gansler DA, Jerram MW, Vannorsdall TD et al. Does the Iowa Gambling Task measure executive function?. Arch Clin Neuropsychol 2011; 26: 706-717
• 128 Sanfilipo MP, Benedict RHB, Weinstock-Guttman B et al. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006; 66: 685-692
• 129 Ciccarelli O, Chen JT. MS cortical lesions on double inversion recovery MRI. Neurology 2012; 78: 296-297
• 130 Seewann A, Kooi EJ, Roosendaal S et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012; 78: 302-308
• 131 Horakova D, Kalincik T, Dusankova JB et al. Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurol 2012; 12: 10
• 132 Roosendaal SD, Bendfeldt K, Vrenken H et al. Grey matter volume in a large cohort of ms patients: relation to MRI parameters and disability. Mult Scler 2011; 17: 1098-1106
• 133 Calabrese M, Atzori M, Bernardi V et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007; 254: 1212-1220
• 134 Amato M, Bartolozzi M, Zipoli V et al. Neocortical volume decrease in relapsing-remitting ms patients with mild cognitive impairment. Neurology 2004; 63: 89-93
• 135 Roosendaal S, Moraal B, Pouwels P et al. Accumulation of cortical lesions in ms: relation with cognitive impairment. Mult Scler 2009; 15: 708-714
• 136 Calabrese M, Agosta F, Rinaldi F et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66: 1144-1150
• 137 Kutzelnigg A, Lucchinetti CF, Stadelmann C et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712
• 138 Benedict RHB, Ramasamy D, Munschauer F et al. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009; 80: 201-206
• 139 Sicotte N, Kern K, Giesser B et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008; 131: 1134-1141
• 140 Geurts JJG, Bö L, Roosendaal SD et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007; 66: 819-827
• 141 Lazeron RHC, de Sonneville LMJ, Scheltens P et al. Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction. Mult Scler 2006; 12: 760-768
• 142 Batista S, Zivadinov R, Hoogs M et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012; 259: 139-146
• 143 Fisher E, Lee JC, Nakamura K et al. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008; 64: 255-265
• 144 Benedict RHB, Wahlig E, Bakshi R et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005; 231: 29-34
• 145 Hoogs M, Kaur S, Smerbeck A et al. Cognition and physical disability in predicting health-related quality of life in multiple sclerosis. Int J MS Care 2011; 13: 57-63
• 146 Kalmar JH, Gaudino EA, Moore NB et al. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis. Neuropsychology 2008; 22: 442-449
• 147 Mitchell AJ, Kemp S, Benito-León J et al. The influence of cognitive impairment on health-related quality of life in neurological disease. Acta Neuropsychiatr 2010; 22: 2-13
• 148 Grasso MG, Troisi E, Rizzi F et al. Prognostic factors in multidisciplinary rehabilitation treatment in multiple sclerosis: an outcome study. Mult Scler 2005; 11: 719-724
• 149 Langdon DW, Thompson AJ. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 1999; 5: 94-100
• 150 Feinstein A. Mood disorders in multiple sclerosis and the effects on cognition. J Neurol Sci 2006; 245: 63-66
• 151 Feinstein A. Multiple sclerosis and depression. Mult Scler 2011; 17: 1276-1281
• 152 Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc 2008; 14: 691-724
• 153 Haase CG, Tinnefeld M, Lienemann M et al. Depression and cognitive impairment in disability-free early multiple sclerosis. Behav Neurol 2003; 14: 39-46
• 154 Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76: 469-475
• 155 Christodoulou C, Melville P, Scherl WF et al. Negative affect predicts subsequent cognitive change in multiple sclerosis. J Int Neuropsychol Soc 2009; 15: 53-61
• 156 Diamond BJ, Johnson SK, Kaufman M et al. Relationships between information processing, depression, fatigue and cognition in multiple sclerosis. Arch Clin Neuropsychol 2008; 23: 189-199
• 157 Bruce JM, Arnett PA. Self-reported everyday memory and depression in patients with multiple sclerosis. J Clin Exp Neuropsychol 2004; 26: 200-214
• 158 Julian L, Merluzzi NM, Mohr DC. The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis. Mult Scler 2007; 13: 81-86
• 159 Kinsinger SW, Lattie E, Mohr DC. Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. Neuropsychology 2010; 24: 573-580
• 160 Lester K, Stepleman L, Hughes M. The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med 2007; 30: 177-186
• 161 Hautzinger R, De Jong-Meyer R. Depressionen. In: Reinecker H, Hrsg. Lehrbuch der Klinischen Psychologie und Psychotherapie. Göttingen: Hogrefe; 2003
• 162 Fisk JD, Pontefract A, Ritvo PG et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14
• 163 Pittion-Vouyovitch S, Debouverie M, Guillemin F et al. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci 2006; 243: 39-45
• 164 Bol Y, Duits AA, Hupperts RMM et al. The psychology of fatigue in patients with multiple sclerosis: a review. J Psychosom Res 2009; 66: 3-11
• 165 Noll KR. Predictors of quality of life in multiple sclerosis: relationships between cognitive, physical, and subjective measures of disease burden. Im Internet: http://repositories.tdl.org/utswmed-ir/bitstream/handle/2152.5/951/NollKyle.pdf?sequence=2
• 166 Morrow SA, Weinstock-Guttman B, Munschauer FE et al. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis. Mult Scler 2009; 15: 998-1005
• 167 Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000; 55: 934-939
• 168 Schwid SR, Tyler CM, Scheid EA et al. Cognitive fatigue during a test requiring sustained attention: a pilot study. Mult Scler 2003; 9: 503-508
• 169 Bol Y, Duits AA, Hupperts RMM et al. The impact of fatigue on cognitive functioning in patients with multiple sclerosis. Clin Rehabil 2010; 24: 854-862
• 170 Parmenter BA, Denney DR, Lynch SG. The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue. Mult Scler 2003; 9: 111-118
• 171 Schreiber H, Kiltz K, Lang M et al. Fatigue, Kognition und Persönlichkeit bei Patienten mit RRMS. Nervenarzt 2010; 81: 39-40
• 172 Baumstarck-Barrau K, Simeoni MC, Reuter F et al. Cognitive function and quality of life in multiple sclerosis patients: a cross-sectional study. BMC Neurol 2011; 11: 17
• 173 Glanz BI, Healy BC, Rintell DJ et al. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. J Neurol Sci 2010; 290: 75-79
• 174 Ozakbas S, Idiman E, Kaya D et al. Effects of mitoxantrone treatment on cognitive and physical disability in patients with multiple sclerosis. Neurology 2008; 70 (Suppl. 01) P02
• 175 Schröder A, Klotz P, Lee DH et al. Stability of cognitive functions under mitoxantrone therapy in patients with progressive multiple sclerosis: a pilot analysis. Clin Neurol Neurosurg 2011; 113: 527-530
• 176 Piehl F, Holmén C, Hillert J et al. Swedish natalizumab (Tysabri) multiple sclerosis surveillance study. Neurol Sci 2011; 31: 289-293
• 177 Iaffaldano P, Viterbo RG, Paolicelli D et al. Impact of Natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLoS ONE 2012; 7: e35843
• 178 Polman CH, O'Connor PW, Havrdova E et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006; 354: 899-910
• 179 Rinaldi F, Calabrese M, Seppi D et al. Natalizumab strongly suppresses cortical pathology in relapsing–remitting multiple sclerosis. Mult Scler 2012; 18: 1760-1762
• 180 Vass K. Natalizumab: Neuer Standard der Therapieeffektivität?. Journal für Neurologie, Neurochirurgie und Psychiatrie 2010; 11: 30-36
• 181 Christodoulou C, MacAllister WS, McLinskey NA et al. Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?. CNS Drugs 2008; 22: 87-97
• 182 Krupp LB, Christodoulou C, Melville P et al. Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology 2011; 76: 1500-1507
• 183 O’Carroll CB, Woodruff BK, Locke DE et al. Is donepezil effective for multiple sclerosis-related cognitive dysfunction? A critically appraised topic. Neurologist 2012; 18: 51-54
• 184 Rosti-Otajärvi E, Hämäläinen P. Rehabilitation for cognitive dysfunctions in persons suffering of Multiple Sclerosis (MS). Cochrane Database Syst Rev 2011; 11
• 185 Thomas PW, Thomas S, Hillier C et al. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 2006; 1